trending Market Intelligence /marketintelligence/en/news-insights/trending/qwkZ2oHMFPUArbCFb0y2wQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Boston Biomedical appoints chief medical officer, chief commercial officer

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Boston Biomedical appoints chief medical officer, chief commercial officer

Boston Biomedical Inc. appointed Edgar Braendle as executive vice president, head of research and development and chief medical officer.

Braendle previously served as president and CEO of ARUP Laboratories, a national clinical and anatomic pathology reference laboratory.

The company also appointed Dee Mahoney as senior vice president and chief commercial officer.

Mahoney was previously the co-founder and president of DMH BioPharm Advisors, a boutique management consultancy.

Boston Biomedical is owned by Sumitomo Dainippon Pharma Co. Ltd.